Activation of the β-catenin signaling pathway and its impact on RPE cell cycle

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 9, 2009, Pages 4471-4476

  Steindl Kuscher, Kerstin ^a   Krugluger, Walter ^b   Boulton, Michael E ^c   Haas, Paulina ^a   Schrattbauer, Karl ^b   Feichtinger, Hans ^d   Adlassnig, Wolfram ^e   Binder, Susanne ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Department of Clinical Chemistry ^*  (Austria)

^c UNIVERSITY OF FLORIDA   (United States)

^d KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CELLULAR RETINALDEHYDE BINDING PROTEIN; CYCLIN D1; CYTOKERATIN 18; EPIDERMAL GROWTH FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; RPE65 PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN; CELL CYCLE PROTEIN; MESSENGER RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; CELL CYCLE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

BETA CATENIN; BIOLOGICAL MARKERS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349233977     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3139     Document Type: Article

References (32)

1. Marmor MF, Wolfensberger TJ. The Retinal Pigment Epithelium: Function and Disease. Oxford, UK: Oxford University Press; 1998.
2. Binder S, Glittenberg CG, Stanzel BV. Transplantation of RPE in AMD. Prog Retin Eye Res. 2007;26:516-554.
3. Binder S, Stolba U, Krebs I. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularisation resulting from age- related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133:215-225.
4. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci. 2004; 45:4151-4160.
5. Van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003 Oct;136(4):688-695.
6. Boulton M. Aging of the retinal pigment epithelium. In: Osbourne N, Chader G, eds. Progress in Retinal Research. Oxford, UK: Pergamon; 1991;125-151.
7. Boulton M, Rozanowska M, Wess T. Ageing of the retinal pigment epithelium: implications for transplantations. Graefes Arch Clin Exp Ophthalmol. 2004;242:76-84.
8. Jarrett S, Boulton M. Antioxidant up-regulation and increased nuclear DNA protection play a key role in adaptation to oxidative stress in epithelial cells. Free Radical Biol Med. 2005;38:1382-1391.
9. Korte GE, Repucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984;42:241-246.
10. Schutt F, Bergmann M, Holz FG, Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44:3663-3668.
11. Schutt F, Davies S, Kopitz J, Holzer FG, Boulton M. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 2000;41:2303-2308.
12. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, et al. Insulin and IGF-1 stimulate the β- Catenin pathway through two signalling cascades involving GSK-3b inhibition and Ras activation. Oncogene. 2000;20:252-259.
13. Hecquet C, Lefevre G, Valtnik M, Engelmann K, Mascarelli F. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci. 2002;43:3091-3098.
14. Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 2001;61:6050-6054.
15. Krugluger W, Seidel S, Steindl K, Binder S. Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and β-catenin transcription in cultured ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol. 2007;245:1543-1548.
16. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmland LM. ARPE-19, A human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
17. Schlunck G, Martin G, Agostini HT, Camatta G, Hansen LL. Cultivation of human retinal pigment epithelial cells from human choroidal neovascular membranes in age-related macular degeneration. Exp Eye Res. 2002;74:571-576.
18. ABI Prism 7700 Sequence Detection System: Relative Quantification of Gene Expression. Bulletin 2. Foster City, CA: PE-Applied Biosystems. 2001;1-36.
19. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci. 2003;116:1175-1186.
20. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998;12:3499-3511.
21. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812-821.
22. Jeon SH, Jeong WJ, Cho JY, Lee KH, Choi KY. Akt is involved in the inhibition of cell proliferation by EGF. Exp Mol Med. 2007;39:491-498.
23. Yan D, Wiesmann M, Rohan M, et al. Elevated expression of axin2 and Hnkd mRNA provides evidence that Wnt/beta catenin signaling is activated in human colon tumors. Proc Natl Acad Sci. 2001;98:14973-14978.
24. Lustig B, Jerchow B, Sachs M, et al. Negative feedback loop of Wnt signalling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22:1184-1193.
25. Eldar-Finkelman H, Seger R, Vandenheede JR, Krebs EG. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signalling pathway in HIH/3T3 cells. J Biol Chem. 1995; 270:987-990.
26. Graham NA, Asthagiri AR. Epidermal growth factor-mediated t-cell factor/lymphoid enhancer factor transcriptional activity is essential but not sufficient for cell cycle progression in nontransformed mammary epithelial cells. J Biol Chem. 2004;279:23517-23524.
27. Moriarty P, Boulton ME, Dickson A, McLoud D. Production of IGF-1 and IGF binding proteins by retinal cell in vitro. Br J Ophthalmol. 1994;78:638-642.
28. Kanuga N, Winton HL, Beauchene L, et al. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci. 2002;43:546-555.
29. Sharma RK, Orr WE, Schmitt AD, Johnson DA. A functional profile of gene expression in ARPE-19 cells. BMC Ophthalmol. 2005;5:25.
30. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and betacatenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5(9):691-701.
31. Nelson WJ, Nusse R. Convergenc of Wnt, β-catenin, and cadherin pathways. Science. 2004;303:1483-1487.
32. Gordon MD, Nusse R. Wnt signalling: multiple pathways, multiple receptors and multiple transcription Factors. J Biol Chem. 2006; 281:22429-22433.